Advertisement

Topics

Merganser Biotech, Inc. Company Profile

21:51 EDT 21st March 2019 | BioPortfolio

Merganser Biotech is a largely virtual, development only company focused on the licensing and development of early stage, novel peptidyl therapeutic approaches to the treatment of human diseases. Its lead project is the development of hepcidin mimetic peptides for the treatment of iron overload in diseases such as beta thalassemia and hemochromatosis. Led by experienced biopharmaceutical executives and having received funding from BioAdvance and angel investors, Merganser intends to advance this program into clinical development.


News Articles [1551 Associated News Articles listed on BioPortfolio]

What Does the Largest Biotech IPO Ever Mean for European Biotech?

With a massive €530M ($604M) raised, US-based Moderna has made a record biotech IPO. The news could give a significant boost to developers of messenger RNA, a technology that is still several years ...

VIDEO: Biotech Showcase 2019: F2G Accelerates Phase IIb Program Vs Life-Threatening Fungal Infections

Ian Nicholson, CEO of F2G, updated Mike Ward during Biotech Showcase 2019 on the progress the biotech company is having...   

PCI Biotech Holding ASA: PCI Biotech: Disclosure of voting rights for Chairman of the Board

Oslo, 13 September 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and ....

VIDEO: Biotech Showcase 2019: Rexgenero Advances CLI-Focused Regenerative Medicine Into Phase III

Joe Dupere, CEO at Rexgenero, reveals to Mike Ward during Biotech Showcase 2019 the four-year-old UK biotech’s plans.    

FIT Biotech Oy: Changes in FIT Biotech’s Board of Directors

FIT Biotech Oy Company release 7.1.2019 at 9:55 EET Changes in FIT Biotech’s Board of Directors FIT Biotech Oy’s (“Company”, FITBIO: FN Finland) Chairman of the Board of Direc...

Are Recent IPO Delays Bad News for European Biotech?

Over the last two weeks, several biotech companies in Europe have decided to postpone IPOs on the stock markets — is this a sign that biotech stocks are underperforming?   Since the end of Octo...

The Top 10 Biotech Companies in Stockholm

As Sweden’s capital, Stockholm is perhaps best known for its picturesque islands and bridges, crayfish festivals, and wondrously preserved medieval architecture, but the city is also a hub of biotec...

Strict regulations hamper biotech farm animal product consumption

Scientists at the University of California at Davis are developing biotech cattle that do not grow horns and biotech cows tha -More- 

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Prestalia [marina biotech]

These highlights do not include all the information needed to use PRESTALIA tablets safely and effectively. See full prescribing information for PRESTALIA.PRESTALIA (perindopril arginine and amlodipin...

Pyridostigmine bromide [rising pharmaceuticals, inc.]

Pyridostigmine Bromide Extended-Release Tablets, 180 mg

Vivotif-b [rebel distributors corp]

Vivotif-B

Stelara [janssen biotech, inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) injection, for subcutaneous or int...

Ctx4 gel 5000 [oral biotech]

CariFree® CTx4 Gel 50001.1% (w/w) sodium fluoride

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

Third-quarter biotech job picture.

New Nonprofit Biotech From Bill and Melinda Gates.

Biotech leaders call for free press.

US law threatens flow of foreign capital to biotech sector.

Genetic data sharing: a new type of capital.

Over the last three decades, various biotech companies, mostly in North America, have become experts in the production, processing and analysis of large volumes of genetic data. They have surpassed th...

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

This phase I clinical study was designed to evaluate the safety of Recombinant Human Papillomavirus Vaccine (6,11,16,18,31,33,45,52,58 Type)(E.Coli)(hereafter called HPV vaccine), manufact...

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Companies [938 Associated Companies listed on BioPortfolio]

Merganser Biotech, Inc.

Merganser Biotech is a largely virtual, development only company focused on the licensing and development of early stage, novel peptidyl therapeutic approaches to the treatment...

Merganser Biotech Inc.

Merganser Biotech was founded by Brian MacDonald and Gene Merutka and is focused on the evaluation of novel hepcidin mimetic peptides for the treatment of beta thalassemia and oth...

BioTech Umeå

The Biotech industry stimulates growth and creates new job opportunities in Sweden. The city of Umeå hosts first-rate biotech research. BioTech Umeå is a driving force helping the industry as well a...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

More Information about "Merganser Biotech, Inc." on BioPortfolio

We have published hundreds of Merganser Biotech, Inc. news stories on BioPortfolio along with dozens of Merganser Biotech, Inc. Clinical Trials and PubMed Articles about Merganser Biotech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merganser Biotech, Inc. Companies in our database. You can also find out about relevant Merganser Biotech, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record